The establishment of a Healthcare System and presence of Major Key Companies along with Rising Prevalence of Epilepsy Coupled With Medical Conditions Are Propelling The Market Growth In North America

The region has a well-established healthcare system, and advanced healthcare infrastructure, which enables the early diagnosis and treatment of epilepsy. Additionally, the presence of major pharmaceutical companies, research institutions, and clinical trial organizations has facilitated the development and commercialization of new drugs and treatment options for epilepsy in the region, the North American epilepsy market is highly competitive, with the presence of several established players and emerging players. These companies are focusing on developing new drugs, expanding their product portfolio, and strengthening their distribution channels to maintain their market position. Further, the rising incidence of Epilepsy in this region. For instance, according to the WHO 2023 report, around 49 per 100 000 people are diagnosed with epilepsy each year, including those living in high-income countries. Moreover, factors such as injury, and trauma have significantly contributed towards the growth of these segments. Thus, these above-mentioned factors are anticipated to propel the market growth in the forecasting period.

Access sample report (including graphs, charts, and figures):https://univdatos.com/report/epilepsy-market/get-a-free-sample-form.php?product_id=40956

North America Epilepsy Market Revenue (2020-2028) – USD Mn

For a detailed analysis of the Global Epilepsy Market browse through – https://univdatos.com/report/epilepsy-market/

• Based on the seizure type, the market is segmented into focal seizure, generalized seizure and non-epileptic seizure. Amongst these, the focal seizure dominated the market in the forecasting period.
• Based on the drug generation the market is segmented into first generation, second generation and third generation. Amongst these, the second-generation drug segment dominates the market.
• Based on end-users the market is segmented into hospitals, clinics and research institutes. Amongst these, the hospital segment is anticipated to grow with a significant CAGR in the forecasted period.

Global Epilepsy Market Segmentation

Market Insight, by Type of Seizure

• Focal Seizure
• Generalized Seizure• Non-Epileptic Seizure

Market Insight, by Generation

• First Generation
  • Second Generation
  • Third Generation

Market Insights, by End-Users

• Hospitals
• Clinics• Research Institutes• Diagnostics Centers

Market Insight, by Region

• North America
  • U.S.
  • Canada
  • Rest of North America
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • India
  • South Korea
  • Rest of APAC
• Rest of the World

Top Company Profiles

• Abbott.
  • Novartis Pharmaceuticals Corporation
  • GSK plc.
  • Sanofi
  • Johnson & Johnson Services, Inc.
  • UCB S.A.,
  • Sumitomo Pharma Co., Ltd.
  • Bausch Health Companies Inc.
  • H. Lundbeck A/S
  • Pfizer Inc

.